Cytek Biosciences Reports Third Quarter 2025 Financial Results

(NASDAQ:CTKB), FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Cytek(R) Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Total revenue for the third quarter of 2025 was $52.3 million, representing a 2% increase compared to […]

Pennant Reports Third Quarter 2025 Results

Pennant Reports Third Quarter 2025 Results Conference Call and Webcast scheduled for tomorrow, November 6, 2025 at 10:00 am MT GlobeNewswire November 05, 2025 EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today

Global Crossing Airlines Reports Third Quarter 2025 Financial Results

(Other OTC:JETMF),(OTC US:JETMF),(Neo:JET.NE),(Neo:JET-B.NE),(Neo:JET),(Neo:JET-B), Record Quarterly Utilization of 9,901 Block Hours Drives Revenue Growth of 11% YoY to $58.0 Million MIAMI, Nov. 05, 2025 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), The Nation's Fastest Growing Charter Airline(TM), today announced its financial and operating

Amplify Energy Provides Strategic Initiatives Update and Third Quarter 2025 Results

Amplify Energy Provides Strategic Initiatives Update and Third Quarter 2025 Results GlobeNewswire November 05, 2025 HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today an update on its strategic initiatives and operating and financial results for the third quarter of 2025. Strategic Initiatives Update

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update

(NASDAQ:ZVRA), 2025 EPS of $(0.01) Q3 2025 net revenue of $26.1 million, driven by MIPLYFFA(R) net revenue of $22.4 million Company to host conference call and webcast TODAY, November 5, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company

Pennant Reports Third Quarter 2025 Results

(NASDAQ:PNTG), EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted diluted

Robinhood Reports Third Quarter 2025 Results

Robinhood Reports Third Quarter 2025 Results GlobeNewswire November 05, 2025 Revenues up 100% year-over-year to a record $1.27 billionNet Deposits were a record $20 billion, and Robinhood Gold Subscribers reached a record 3.9 millionDiluted EPS up 259% year-over-year to $0.61Robinhood now up to 11 business lines each generating ~$100 million or more in annualized revenues

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes GlobeNewswire November 05, 2025 POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the Centers for Medicare & Medicaid

Greif Reports Fourth Quarter and Fiscal 2025 Results

Greif Reports Fourth Quarter and Fiscal 2025 Results GlobeNewswire November 05, 2025 DELAWARE, Ohio, Nov. 05, 2025 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, today announced two-month fourth quarter and eleven-month fiscal 2025 results. On June 30, 2025, we entered into a definitive agreement to

Senseonics Holdings, Inc. Reports Third Quarter Financial Results

(NYSE MKT:SENS), Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NYSE American: SENS), a

Scroll to Top